Active, not recruitingNot applicableNCT07196046

Product Responsiveness to Enhanced Bioavailability Curcumin Dietary Supplements in Adults

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ultra Botanica LLC
Principal Investigator
Adam Payne, CEO, MBA
Ultra Botanica LLC
Intervention
Supplement 2(dietary_supplement)
Enrollment
30 target
Eligibility
30-85 years · All sexes
Timeline
20252026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07196046 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials